Sophie A. L.
- Country
- France
- Department
- Oncologie
Research Overview
- Phase 3 Study of Vepugratinib and Combination Therapy in Adults with Untreated FGFR3-Altered Locally Advanced or Metastatic Urothelial Carcinoma
- A Phase 3, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (KEYNOTE-564)
- Perioperative Durvalumab plus Cisplatin-Based Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer: A Global Open-Label Single-Arm Study
Data & Insights
Has run more than one trial at 265 of 537 partner sites.
Specializations
Urological Oncology
The investigator specializes in treating various forms of urological cancers, with particular emphasis on advanced bladder and urothelial conditions.
- Metastatic Urothelial Cancer
- Muscle-invasive Bladder Cancer
- Locally Advanced Bladder Cancer
Research includes innovative therapeutic approaches combining immunotherapy with conventional treatments for bladder cancer management.
Prostate Cancer Research
Focuses on advanced treatments for various stages of prostate cancer, particularly exploring novel therapeutic combinations.
- Metastatic Castration-Sensitive Prostate Cancer
- Castration-Resistant Prostate Cancer
- High-Risk Localized Prostate Cancer
Investigates targeted therapies including hormone treatments and radiopharmaceuticals for prostate cancer management.
Gynecologic Oncology
Conducts research in advanced gynecological cancers, with specific focus on ovarian cancer treatment strategies.
- Advanced Ovarian Cancer
- Fallopian Tube Cancer
- Cervical Cancer
Explores combination therapies involving targeted agents, immunotherapy, and maintenance treatments for gynecologic malignancies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.